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Abstract 
Background: Surgical site infections (SSI) are associated with increased morbidity and mortality. To lower the 
incidence of SSI, antimicrobial prophylaxis is given 30–60 min before certain types of surgeries in both human and 
veterinary patients. However, due to the increasing concern of antimicrobial resistance, the benefit of antimicrobial 
prophylaxis in clean orthopaedic and neurosurgeries warrants investigation. The aims of this retrospective cross‑
sectional study were to review the rate of SSI and evaluate the compliance with antimicrobial guidelines in dogs at a 
veterinary teaching hospital in 2012–2016. In addition, possible risk factors for SSI were assessed.
Results: Nearly all dogs (377/406; 92.9%) received antimicrobial prophylaxis. Twenty‑nine dogs (7.1%) did not receive 
any antimicrobials and only four (1.1%) received postoperative antimicrobials. The compliance with in‑house and 
national protocols was excellent regarding the choice of prophylactic antimicrobial (cefazolin), but there was room 
for improvement in the timing of prophylaxis administration. Follow‑up data was available for 89.4% (363/406) of the 
dogs. Mean follow‑up time was 464 days (range: 3–2600 days). The overall SSI rate was 6.3%: in orthopaedic surgeries 
it was 6.7%, and in neurosurgeries it was 4.2%. The lowest SSI rates (0%) were seen in extracapsular repair of cranial 
cruciate ligament rupture, ulnar ostectomy, femoral head and neck excision, arthrotomy and coxofemoral luxation 
repair. The highest SSI rate (25.0%) was seen in arthrodesis. Omission of antimicrobials did not increase the risk for SSI 
(P = 0.56; OR 1.7;  CI95% 0.4–5.0). Several risk factors for SSI were identified, including methicillin‑resistant Staphylococ-
cus pseudintermedius carriage (P = 0.02; OR 9.0;  CI95% 1.4–57.9) and higher body temperature (P = 0.03; OR 1.69;  CI95% 
1.0–2.7; mean difference + 0.4 °C compared to dogs without SSI).
Conclusions: Antimicrobial prophylaxis without postoperative antimicrobials is sufficient to maintain the overall rate 
of SSI at a level similar to published data in canine clean orthopedic and neurosurgeries.
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Background
Surgical site infection (SSI) is defined as an infection that 
emerges after surgery [1]. This inherent risk in surgical 
procedures is associated with increased morbidity, costs, 
and even death [2–4]. Antimicrobial prophylaxis in sur-
gery refers to antimicrobial administration in the imme-
diate proximity of the surgical procedure. According to 
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the European Center for Disease Prevention and Con-
trol, antimicrobial prophylaxis beyond 24 h post-surgery 
in humans is not recommended in clean and clean-con-
taminated surgeries. Moreover, the Swedish Council on 
Health and Technology Assessment states that for closed 
fractures and elective prosthetic surgery, there is scien-
tific support for limiting antimicrobial administration to 
prophylaxis only [5]. According to the most recent Cent-
ers for Disease Control and Prevention (CDC) guideline 
for SSI prevention, the recommendation is to administer 
the surgical prophylactic antimicrobial in time to allow 
the chosen drug to reach sufficient tissue concentrations 
at the surgical site before the incision is made [1]. Pre- 
or postoperative antimicrobial administration is not sug-
gested unless given for other reasons such as treatment of 
a concurrent infection [1, 6].
In veterinary medicine, the current Nordic recommen-
dations are for reduced use of antimicrobial prophylaxis, 
and emphasize strict surgical asepsis. According to the 
Danish Antibiotic Use Guidelines for Companion Ani-
mal Practice, prophylaxis is not required for patients 
with American Society of Anesthesiologists (ASA) clas-
sification 1–2 with clean procedures, or for apyretic ASA 
3 patients undergoing a clean or clean-contaminated 
procedure [7]. The respective Swedish guidelines state 
that antimicrobial prophylaxis is not suggested in clean 
orthopaedic procedures in low-risk patients, even when 
a surgical implant other than a joint prosthesis is placed 
[8]. Finnish guidelines similarly advise that antimicrobial 
prophylaxis is not recommended in clean and clean-con-
taminated soft tissue surgeries that take less than 60 min. 
However, in clean orthopaedic surgeries the recom-
mended protocol consists of a first-generation cephalo-
sporin given 30–60 min before the surgical incision, and 
the antimicrobial administration is continued until the 
end of surgery [9]. Our hospital guidelines are in accord-
ance with the Finnish guidelines.
Research results regarding the optimal use of anti-
microbials in preventing surgical site infections is 
inconclusive. Many studies suggest that postoperative 
antimicrobial administration after clean orthopaedic sur-
geries is protective against SSI in dogs [10–15]. However, 
there is also evidence that antimicrobial administration 
in the postoperative period has no protective effect on 
the incidence of SSI [16, 17]. Furthermore, recent evi-
dence suggests that the SSI rate in certain neurosurgeries 
is very low, even without the use of prophylactic antimi-
crobials [18]. Therefore, stronger evidence either for or 
against the use of antimicrobial prophylaxis in clean sur-
geries is required, particularly in light of the alarmingly 
increasing antimicrobial resistance [2].
Reported SSI rates in canine clean orthopaedic and 
neurosurgeries range from 0.6% to 7.1% [2, 18, 19]. 
However, higher SSI rates of up to 21.3% and 25.9% 
have been reported in tibial plateau levelling osteotomy 
(TPLO) surgeries [15, 17]. In human medicine, risk fac-
tors for surgical site infections include obesity, concur-
rent diseases, breaks in aseptic technique, prolonged 
hospitalization and methicillin-resistant Staphylococcus 
aureus (MRSA) colonization [2]. In veterinary medicine, 
additional risk factors associated with an increased SSI 
incidence include more people present in the operating 
room, prolonged duration of anaesthesia and surgery, 
presence of a drain, concurrent endocrinopathy and the 
use of propofol [2, 3].
This study aimed to retrospectively review  the SSI 
rate in canine clean orthopaedic and neurosurgeries at 
the Veterinary Teaching Hospital of the University of 
Helsinki (Finland) and to relate the SSI rate and perio-
perative antimicrobial use to previously published data. 
Further aims were to evaluate compliance with in-house 
and national antimicrobial guidelines at a veterinary 
teaching hospital, and to identify possible risk factors for 
SSIs in order to raise hypotheses for prospective studies. 
We expected that the SSI rate would be within the pre-
viously cited range (0.6–7.1%) and that the compliance 
with antimicrobial guidelines would be good.
Methods
Study design
This was a cross-sectional retrospective study. The study 
population included dogs that had undergone a clean 
orthopaedic or neurosurgery between January 2012 and 
December 2016 at the Veterinary Teaching Hospital of 
the University of Helsinki. Surgeries comprised arthro-
desis, arthroscopy, arthrotomy, cruciate ligament rupture 
repair, femoral head and neck excision, hemilaminec-
tomy and laminectomy, patellar luxation repair, surgical 
fracture stabilization, and ulnectomy. Prosthetic surger-
ies were excluded because this type of surgery was not 
performed during the study period.
Data collection
Data were collected from the electronic medical records 
(Provet Net, FNS Finland) of all dogs that had under-
gone the aforementioned surgical procedures. Informa-
tion retrieved included signalment, concurrent diseases, 
ASA classification, being a risk patient (i.e. screened 
for the carriage of multidrug resistant (MDR) bacteria; 
for further information on risk patient classification, 
see Additional file  1), known carriage of MDR bacte-
ria, administration of antimicrobials (preoperatively: 
before admission to hospital, prophylactic: parenteral 
administration of antimicrobials in the immediate prox-
imity to surgery, or postoperatively: beyond 24  h after 
surgery), timing of antimicrobial prophylaxis in relation 
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to skin incision, administration of local anaesthetic 
(regional or epidural anaesthesia), duration of anaes-
thesia (from induction to extubation) and surgery (from 
skin incision to closure), lowest rectal body temperature 
and lowest mean arterial blood pressure (MAP) value 
(when < 60  mmHg), as well as duration of hypotension 
(MAP < 60  mmHg) during the anaesthesia, whether or 
not an implant was placed, duration of hospitalization, 
follow-up visits, bacterial culture results and treatment 
of SSI. Definitions of SSI followed the CDC guidelines 
(Table 1) [20]. If signs of SSI, such as redness, pain, swell-
ing, incisional drainage or incisional dehiscence were 
mentioned, or if a bacterial culture of the surgical site 
was performed, the dog was considered as having a sur-
gical site infection. If no abnormalities suggesting an SSI 
were mentioned in the patient record from the post-sur-
gical follow-up visit, the surgical site was considered as 
not infected.
Hospital protocols for surgical asepsis and use 
of antimicrobials in clean orthopaedic and neurosurgeries
The fur was clipped, and the surgical site was first asep-
tically scrubbed with disposable swabs using 4% chlo-
rhexidine gluconate (Hibiscrub, BCM Ltd., United 
Kingdom) then wiped with 70% (v/v) ethanol (Erisan 
Dermades, KiiltoClean Oy, Finland) in a designated 
preparation room. The dog was then transported to the 
operating room where the surgical site was again wiped 
with 70% ethanol. The surgical site was covered with 
disposable sterile drapes and an adhesive film (Opsite, 
Smith&Nephew, United Kingdom).
The surgery rooms were reserved for clean surger-
ies only, and a maximum of seven persons were allowed 
in the room. All personnel and observers in the operat-
ing room wore a surgical mask and cap. All members of 
the surgical team followed the same aseptic preparation 
of hands and arms before entering the operating room. 
The surgical hand preparation was performed accord-
ing to the WHO guidelines [21]. The primary surgeon 
and assistant(s) wore a sterile surgical gown and gloves. 
Double gloving was used in all orthopaedic surgeries. The 
gloves were changed during surgery if any disruption in 
aseptic technique was suspected.
The anaesthetic protocol and pain medication were 
planned individually for each patient by an anaesthesi-
ologist. To comply with the hospital protocol for pro-
phylactic antibiotic administration, the antimicrobial 
was given intravenously 30–60  min before the esti-
mated time of incision. The first-choice antimicrobial 
was cefazolin at a dose of 22 mg/kg body weight (BW), 
Table 1 Surgical site infection definitions according to the CDC guidelines [20]
SSI, surgical site infection
Superficial incisional SSI Infection occurs within 30 days of surgery
AND
Involves only skin or subcutaneous tissue of the incision
AND
At least ONE of the following:
 Purulent drainage
 Positive microbial culture from the incision site
 At least one of the following symptoms: pain or tenderness, localized swelling, redness or heat
 Diagnosis of SSI is made by a veterinarian
Deep incisional SSI Infection occurs within 30 days of surgery or within 1 year if implant is in place
AND
Involves deep soft tissue (fascia, muscle etc.) of the incision
AND
At least ONE of the following:
 Purulent drainage from the deep incision
 Deep incision dehisces or is opened by the surgeon when the dog has at least one of the following symptoms UNLESS 
bacterial culture of the incision is negative:
  Fever
  Localized pain or tenderness
 An abscess or other evidence of infection in the deep soft tissues of the incision is found on examination, reoperation, histo‑
pathology or imaging
Organ/Space SSI Infection occurs within 30 days of surgery or within 1 year if implant is in place
AND
Involves any area other than the incision which was opened or manipulated during surgery
AND
At least ONE of the following:
 Purulent drainage
 Positive bacterial culture
 An abscess or other evidence of infection involving the organ/space found on examination or by histopathology or diag‑
nostic imaging
 Diagnosis of SSI made by a veterinarian
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and the dose was repeated at 90 min intervals until the 
end of surgery. After surgery, the incision was covered 
with a sterile bandage. After extubation, the dog was 
transported to the recovery room, where it was closely 
monitored for post-anaesthetic complications and 
pain until fully recovered. Postoperative antimicrobi-
als were not routinely administered. The dog was either 
discharged or transferred to the intensive care unit for 
postoperative monitoring.
Data and statistical analysis
Data were entered into an Epi-Info database (v. 7.2, 
CDC). Data validation included visual inspection and 
checking certain data (date and time variables; anti-
microbial use for the treatment of SSI and the name of 
the drug) for logical consistency by programmed SAS 
scripts. After correcting discrepancies (three errors in 
time of hospitalization and one error in the date of sur-
gery), a randomly selected sample of 20 patients was 
used for independent quality control by comparing the 
sample with the data in the electronic patient records. 
The accepted error rate was 0% for critical and < 0.5% 
for other data. The critical variables were the carriage 
of MDR bacteria, presence of an implant, antimicrobial 
administration, systemic disease, presence of SSI, the 
result of a bacterial culture for SSI, treatment of SSI, 
and consequences of SSI.
Descriptive statistics of the entire data were presented 
as frequency and percentage distributions for categorical 
variables; for continuous variables, data were presented 
as mean, standard deviation (SD), and range values. To 
assess potential risk factors associated with SSI, uni-
variable and multivariable logistic regression models 
were used. The dependent variable was the presence or 
absence of SSI. Other variables served as independent 
variables. Univariable and multivariable logistic regres-
sion analyses were used to examine the probability of 
infection using Firth’s bias adjustment method to take 
into account the rareness of the events [22]. When dogs 
had several interventions on different dates, each inter-
vention was recorded as a separate surgery and the 
interventions were addressed individually in statistical 
analysis. Factors that were identified as meaningful in the 
univariable model (P < 0.1) were inserted into a multivari-
able logistic regression model, where the main effects of 
these factors were all simultaneously included as fixed 
effects; no interactions between the factors were studied 
due to the rareness of outcome events. Main conclusions 
were drawn from the multivariable model. For all analy-
ses, a P-value of < 0.05 was considered significant. All sta-
tistical analyses were performed using  SAS® System for 
Windows (v. 9.4, SAS Institute Inc., Cary, NC, USA).
Results
Data were collected for 406 dogs, of which 202 (49.8%) 
were females and 204 (50.2%) were males. A total of 
101 different breeds were included; mixed breed dogs 
were most common (50), followed by Dachshunds (23) 
and Labrador retrievers (13). The mean ± SD age was 
7.6 ± 3.5 (range 2.0–18.0) years and BW was 16.5 ± 14.0 
(range 1.0–96.0) kg. All dogs were classified as ASA class 
2. Screening for MDR bacteria had been preoperatively 
performed on 26 dogs (i.e. classified as risk patients), of 
which six were found to be carriers of methicillin-resist-
ant Staphylococcus pseudintermedius (MRSP). Surgical 
procedures performed are presented in Table 2.
Antimicrobial administration
Altogether, 377/406 dogs (92.9%) received prophylac-
tic antimicrobials (Table  2). Five of the 377 dogs also 
received antimicrobials during the week preceding sur-
gery for a disease unrelated to the surgical procedure. 
Further, four dogs (1.1%) received surgery-related pro-
phylactic antimicrobials as well as postoperative antimi-
crobials due to revision fracture stabilization surgery (2), 
recurrent urinary tract infections (1), and suspected aspi-
ration pneumonia (1). Nearly all of the dogs that received 
surgical prophylaxis (370/377, 98.1%) were administered 
cefazolin. Dogs known to be carriers of MRSP (n = 6) did 
not receive cefazolin. Instead, they received amikacin 
(3), clindamycin (1), enrofloxacin (1), or trimethoprim/
sulfamethoxazole (1) according to the susceptibility pro-
file of the MRSP bacterial strain. In addition, one dog 
received ampicillin.
The time from prophylactic antimicrobial adminis-
tration to skin incision was available for 357/377 dogs 
(94.7%) (Table  2). Altogether, 215/357 dogs (60.2%) 
received antimicrobial prophylaxis 30–60  min before 
incision, according to the hospital protocol; 87 dogs 
(24.4%) received it > 60  min before incision, 41 dogs 
(11.5%) received it < 30 min before incision, and 14 dogs 
(3.9%) received it after the surgical incision. Antimi-
crobial prophylaxis was repeated according to hospital 
protocol during the surgery (i.e. at 90  min intervals) in 
306/377 dogs (81.2%).
Intraoperative variables
Information regarding the duration of anaesthesia and 
surgery was available for 320/406 dogs (78.8%) and 
382/406 dogs (94.1%), respectively. Transient hypotension 
was reported in 126/406 dogs (31.0%). Further data on 
intraoperative variables are presented in Tables 3 and 4.
Occurrence and treatment of SSI
Only dogs with follow-up information (363/406, 89.4%) 
were included in further analysis of SSI occurrence. Mean 
Page 5 of 10Välkki et al. Acta Vet Scand           (2020) 62:53  
follow-up time was 464  days (range 3–2600) (Table  5). 
SSI was diagnosed in 23/363 dogs (6.3%), of which 10 
(43.5%) had a superficial and 13 (56.5%) a deep infec-
tion. Mean time of SSI diagnosis was 68  days (median 
15; range 4–522). Ten cases of SSI were seen within the 
first 2 weeks after surgery. In orthopaedic surgeries, the 
SSI rate was 6.7% (21/315), with the highest frequen-
cies in arthrodesis (3/12, 25.0%) and arthroscopy (4/34, 
11.8%), whereas in TPLO the SSI rate was 7.7% (5/65), in 
fracture stabilization 6.5% (6/93), and in neurosurgeries 
4.2% (2/48). Due to SSI, 11 dogs underwent revision sur-
gery, and the implant was removed from eight of these 
dogs. One dog was euthanized due to SSI at the owner’s 
request. Remarkably, none of the 26/363 dogs (7.2%) that 
did not receive any antimicrobials got an SSI. Bacterial 
culture was taken in 15/23 (65.2%) SSI cases; all of these 
cultures were positive. The most commonly cultured 
bacterium was S. pseudintermedius (n = 9), one of which 
Table 3 Intraoperative variables describing the representativeness of the data
a SD, standard deviation
b MAP, mean arterial pressure
Variable All dogs (406) Dogs with follow-up (363)
Mean ± SDa (range) Mean ± SD (range)
Duration of anaesthesia (min) 245.7 ± 75.1 (100–495) 248.7 ± 76.4 (100–495)
Duration of surgery (min) 126.9 ±  54.3 (20–345) 127.4 ± 53.8 (20–345)
Lowest  MAPb (if < 60 mmHg) during surgery (mmHg) 49.5 ± 5.2 (35–55) 49.5 ± 5.0 (35–55)
Duration of hypotension (MAP < 60 mmHg) (min) 26.4 ± 22.0 (5–125) 26.0 ± 21.5 (5–125)
Lowest body temperature during surgery (°C) 36.1 ± 0.9 (33.2–39.7) 36.1 ± 0.9 (33.2–39.7)
Yes (%) Yes (%)
Antimicrobial administered 377 (92.9) 337 (92.8)
Implant placed 279 (68.7) 251 (69.1)
Propofol administered 349 (86.0) 311 (85.7)
Table 2 Use of antimicrobials in different surgical procedures, included to evaluate the compliance with existing national 
and in-house guidelines
a Preop, preoperatively: before admission to surgery
b Parenteral administration of antimicrobials in the immediate proximity to surgery. This group also included dogs with preoperative and postoperative antimicrobial 
administration
c Postop, postoperatively: after surgery or discharge
d Number of dogs with information regarding the time from antimicrobial administration to skin incision
e Tibial plateau levelling osteotomy
Surgical procedure No. of dogs Dogs receiving antimicrobials Dogs not receiving 
antimicrobials
Dogs with missing data 
regarding the time 
of antimicrobial  
administration
Dogs receiving 
antimicrobial prophylaxis 
between 30 and 60 min 
before incision
Preopa Prophylaxisb Postopc
All 406 5 377 4 29 20 215/357d (60.2%)
Fracture stabilization 108 2 102 2 6 6 61/96d (63.5%)
Cranial cruciate ligament 
rupture repair
92 1 80 1 12 4 38/76d (50.0%)
TPLOe 71 1 60 1 11 3 24/57d (42.1%)
Extracapsular repair 21 – 20 – 1 1 14/19d (73.7%)
Patellar luxation repair 57 2 52 – 5 1 32/51d (62.7%)
Hemilaminectomy and 
laminectomy
54 – 54 1 – 3 30/51d (58.8%)
Arthroscopy 39 – 36 – 3 4 21/32d (65.6%)
Ulnar ostectomy 18 – 16 – 2 1 10/15d (66.7%)
Arthrodesis 14 – 14 – – 1 7/13d (53.8%)
Femoral head and neck 
excision
13 – 12 – 1 – 8/12d (66.7%)
Arthrotomy 6 – 6 – – – 4/6d (66.7%)
Coxofemoral luxation repair 5 – 5 – – – 4/5d (80%)
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Table 4 Univariable and multivariable logistic regression results for the risk factors associated with surgical site infection
Patients with follow-up data 
(n=363)
Univariable logistic regression Multivariable logistic regression
Binary variables All patients
(n = 406)
Infection
(n = 23)
No infection
(n = 340)
Unadjusted OR
(95% CI)
Wald
P
Adjusted OR
(95% CI)
Wald
P
n % n % n % OR1
Sex (male vs. female) 406 50.2 13 56.5 165 48.5 1.36 (0.59-3.15) 0.467
MRSP carrier vs. no 6 1.5 2 8.7 4 1.2 8.69 (1.55-48.85) 0.014 9.03 (1.41-57.92) 0.020
Risk patient for MDR bacterium carriage 26 6.4 2 8.7 24 7.1 1.50 ( 0.37-6.07) 0.568
Other disease Yes vs. No 27 6.7 2 8.7 24 7.1 1.50 (0.37-6.07) 0.568
Medication for concurrent disease 11 2.7 1 4.3 9 2.6 2.32 (0.36-14.89) 0.372
Procedure1
Fracture fixation (reference) 108 29.7 6 26.1 87 25.6 1.00
    Hemilaminectomy and laminectomy 54 14.8 2 8.7 46 13.5 0.72 (0.16-3.29) 0.676
    CCL2 repair 92 25.3 5 21.7 79 23.2 0.93 (0.29-3.04) 0.906
    Patellar luxation repair 57 15.7 3 13.0 53 15.6 0.88 (0.23-3.41) 0.854
    Arthroscopy 39 10.7 4 17.4 30 8.8 1.97 (0.55-7.18) 0.295
    Arthrodesis 14 3.8 3 13.0 9 2.6 4.96 (1.10-22.37) 0.037
Perioperative antibiotic Yes vs. No 377 92.9 21 91.3 316 92.9 0.67 (0.17-2.69) 0.568
Regional block Yes vs. No 148 36.5 8 34.7 123 36.2 1.06 (0.35-3.21) 0.922
Epidural Yes vs. No 162 39.9 10 43.5 133 39.1 1.21 (0.41-3.53) 0.729
Propofol used Yes vs. No 349 86.0 20 86.9 291 85.6 1.00 (0.30-3.25) 0.993
Implant Yes vs No 279 68.7 18 78.3 233 68.5 1.55 (0.58-4.14) 0.383
Antimicrobial prophylaxis repeated Yes v. No 306 75.4 18 85.7 257 81.3 1.22 (0.37-4.00) 0.740
Hypotension Yes vs. No 126 31 5 21.7 107 31.5 0.65 (0.24-1.73) 0.383
Continuous variables All patients
(n = 406)
Infection
(n = 23)
No infection
(n = 340)
Unadjusted OR
(95% CI)
Univariate
P
Adjusted OR
(95% CI)
Multiple regression
P
n mean n mean n mean
Age (years) 406 7.6 23 7.0 340 7.6 0.96 (0.84-1.08) 0.467
Weight (kg) 406 16.5 23 21.2 340 16.3 1.02 (0.99-1.05) 0.086 1.01 (0.98-1.04) 0.440
Hospitalization before surgery (days) 406 1.2 23 1.0 340 1.2 0.83 (0.30-2.27) 0.720
Antimicrobial to incision (min) 357 48 19 47 301 48 1.00 (0.98-1.01) 0.951
Lowest perioperative temperature (°C) 405 36.1 23 36.5 339 36.1 1.67 (1.05-2.66) 0.029 1.69 (1.04-2.73) 0.033
Lowest intraoperative BP (mmHg) 126 49.5 5 51.0 107 49.4 1.05 (0.88-1.26) 0.583
Duration of hypotension (min) 126 26.4 5 21 107 26.3 1.00 (0.96-1.04) 0.836
Duration of surgery (min) 382 127 23 135 340 127 1.00 (0.99-1.01) 0.456
Duration of anesthesia (min) 320 246 4 260 74 248 1.00 (0.99-1.01) 0.448
Hospitalization (days) 406 1.7 23 1.7 340 1.7 1.04 (0.89-1.23) 0.621
0.01           0.1            1                 10           100
1 Only procedures with at least one infection were included
2 Cranial cruciate ligament
Table 5 Data on  the  follow-up time, SSI rates, time of  SSI diagnosis, and  antimicrobial administration protocol 
in different groups of procedures
a SSI, surgical site infection
b TPLO, tibial plateau levelling osteotomy
Surgical procedure Dogs 
with follow-up 
information (n)
Follow-up time 
mean (range) 
(days)
SSIa 
diagnosed 
n (%)
Time of SSI diagnosis 
mean (range) (days)
Antimicrobial 
administration
Yes (n) No (n)
All 363 464 (3–2600) 23 (6.3) 68 (4–522) 337 26
Fracture stabilization 93 476 (3–2600) 6 (6.5) 30 (4–82) 87 6
Cranial cruciate liga‑
ment repair
TPLOb 65 588 (12–1859) 5 (7.7) 235 (15–522) 56 9
Extracapsular stabiliza‑
tion
19 395 (11–2594) 0 – 18 1
Patellar luxation repair 56 425 (11–2147) 3 (5.4) 13 (12–15) 51 5
Hemilaminectomy and laminectomy 48 393 (5–2051) 2 (4.2) 7 (7) 48 0
Arthroscopy 34 515 (11–2201) 4 (11.8) 13 (11–16) 31 3
Ulnar ostectomy 17 336 (30–963) 0 – 16 1
Arthrodesis 12 288 (40–1031) 3 (25) 32 (5–71) 12 0
Femoral head and neck excision 10 562 (14–2041) 0 – 9 1
Arthrotomy 6 592 (58–1594) 0 – 6 0
Coxofemoral luxation repair 3 219 (12–397) 0 – 3 0
Page 7 of 10Välkki et al. Acta Vet Scand           (2020) 62:53  
was MRSP. Single cases of Escherichia coli, Group B 
streptococci, S. aureus, Pasteurella sp., Corynebacterium 
sp., and Enterococcus faecalis were found. Two of the 
dogs diagnosed with SSI were carriers of MRSP; in these 
two dogs, the SSI was caused by MRSP and susceptible S. 
pseudintermedius, respectively.
Altogether, 16/23 dogs with SSI were treated with sys-
temic antimicrobials: cephalexin (n = 7), amoxicillin/cla-
vulanic acid (n = 4), clindamycin (n = 3), trimethoprim/
sulfamethoxazole (n = 1), and amoxicillin and clinda-
mycin (n = 1). Seven dogs were treated with only topical 
agents.
Risk factors for SSIs
In the risk factor analysis, omission of antimicro-
bial administration did not increase the risk for SSI 
(P = 0.56; OR 1.7;  CI95% 0.4–5.0). However, MRSP car-
riage (P = 0.02; OR 9.0;  CI95% 1.4–57.9) and periopera-
tively measured higher body temperature (P = 0.03; OR 
1.69;  CI95% 1.0–2.7; mean difference + 0.4 °C compared to 
dogs without SSI) were shown to be risk factors for SSI 
(Table  4). In the univariate analysis, pairwise compari-
sons of arthrodesis and fracture fixation indicated that 
arthrodesis could increase the risk of SSI compared to 
fracture fixation, as the nominal P-value was statistically 
significant (P = 0.04; OR 4.96;  CI95% 1.1–22.4). However, 
the overall test for differences between procedures in the 
risk of SSI was statistically insignificant (P = 0.21).
Discussion
The overall SSI rate in our study was 6.3%, which can be 
considered satisfactory compared with previous studies. 
Of all patients, 92.9% received antimicrobial prophylaxis. 
This reflects good compliance with in-house and national 
antimicrobial protocols, which underline that no postop-
erative antimicrobials are recommended in clean ortho-
paedic or neurosurgeries [9].
According to our findings, prophylactic antimicrobial 
administration is sufficient to maintain SSI rates at an 
acceptable level in clean orthopaedic and neurosurgeries. 
Since only four dogs received postoperative antimicrobi-
als, we could not investigate the effect of postoperative 
antimicrobial administration on SSI rate. Nevertheless, 
our data indicate that even complete omission of antimi-
crobials was not associated with increased risk for SSI. It 
is important to note that since very few patients (7.2%) 
did not receive any antimicrobials, the risk estimate for 
performing the surgery without antimicrobials is uncer-
tain. Strict aseptic practice, proper surgical technique, 
balanced anaesthesia, and careful SSI surveillance are key 
issues in SSI prevention. Although single doses of anti-
microbial prophylaxis for an individual lead to minimal 
antimicrobial exposure, the cumulative amount of drugs 
used in animals undergoing surgery is significant, and 
may impact the resistance on a population level. There-
fore, more research on the impact of diminishing antimi-
crobials in veterinary surgeries is warranted.
Compliance with antimicrobial protocols regarding 
the choice of prophylactic antimicrobial was excellent, 
as cefazolin was administered for nearly all dogs receiv-
ing antimicrobial prophylaxis. Cefazolin is the recom-
mended antimicrobial in orthopaedic surgery due to its 
rapid equilibrium between plasma and surgical wound 
fluid, favourable antimicrobial spectrum, sustained tis-
sue concentrations, low toxicity, and low cost [23, 24]. 
In our study, 71.7% of the dogs received the first antimi-
crobial within 60 min before surgical incision. This is in 
concordance with a previous study by Weese and Halling 
[25], in which 70.5% of the patients received antimicrobi-
als within 60 min before surgery. The mean time between 
the administration of the first antimicrobial dose and the 
surgical incision was 48 min, which is within the recom-
mended time frame of 30–60 min [23, 26]. Although tim-
ing of the prophylaxis was suboptimal in one-third of the 
cases, the timing of antimicrobial prophylaxis was not 
shown to be a risk factor for SSI in our study.
One of the encouraging findings in our study was that 
the SSI rate after TPLO surgeries was 7.7% without the 
use of postoperative antimicrobials. In previous studies, 
the SSI rate without administration of postoperative anti-
microbials has been reported to be 19.7% [15], 17.0% [17], 
10.7%, [10] and 2.5% [13]. Compared with these stud-
ies, the SSI rate of TPLO surgeries in our study is fairly 
low. Based on the literature, the risk of SSI after TPLO 
surgeries appears to be higher than that of other clean 
orthopaedic procedures. Reported SSI rates range from 
2.9% to 25.9% [10, 12, 13, 15, 17, 27, 28]; postoperative 
antimicrobial administration has been shown to be a pro-
tective factor against SSI in most of these studies [10–13, 
15, 28]. However, due to increasing concern regarding 
antimicrobial resistance, it is crucial to pay attention to 
a rigorous aseptic technique and other factors that affect 
the SSI rate in order to minimize the importance of anti-
microbial use. In TPLO surgeries, the elevated SSI rate 
has been attributed to the use of non-locking plates [15], 
aggressive periosteal dissection, reduced soft tissue cov-
erage of the proximal tibia, thermal bone necrosis dur-
ing osteotomy, and presence of an implant [27, 29]. In 
addition, TPLO without using a jig predisposes patients 
to inaccurate osteotomy angulation, fibular fracture, and 
fixation failure [30, 31].
Displeasingly high SSI rates were found in our study 
after arthroscopies (4/34; 11.8%) and arthrodeses (3/12; 
25%), although the total number of these types of surger-
ies was low. The SSI rate after joint arthrodeses in pre-
vious reports has ranged from 2.6% to 18.2% [32–34], 
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but the use of antimicrobials was not reported in these 
studies. Our data did not reveal reported risk factors 
such as duration of anaesthesia, surgical time or intra-
operative hypotension that would explain the high SSI 
rate in our data [19, 35]. Further, due to the retrospec-
tive nature of the study, information not mentioned in 
the patient records could not be assessed. Therefore, 
no specific reason for the high SSI rate in these types of 
surgeries could be identified. In attempt to shed light on 
the high rate of SSIs in arthroscopies in this study, we 
reviewed more recent data on an additional 28 arthrosco-
pies with follow-up information from 2017 to 2018. This 
review revealed that none of these arthroscopies resulted 
in a SSI. In any case, this is a subject warranting further 
investigations.
Earlier reports on SSI rate in neurosurgeries are scarce. 
In the study by Dyall et al. [18] the SSI rate was only 0.6% 
without any use of antimicrobials, which is exceptionally 
low compared with other clean surgeries. In human med-
icine, the reported SSI rate ranges from 0.7 to 12% [36]. 
In our study, the SSI rate in neurosurgeries was 4.2%, 
which can be considered satisfactory.
In our study, carriage of MRSP was shown to be a risk 
factor for SSI in the multivariate analysis, although the 
number of patients was low, as demonstrated by the wide 
confidence interval. Carriage of MRSP has also been 
shown to be a risk factor in a study by Nazarali et al. [13]. 
Patients carrying MRSP often have a history of numerous 
or prolonged antimicrobial therapies or underlying skin 
or ear problems, as MRSP is frequently isolated from the 
skin of dogs with active or recent skin disease [37, 38]. 
Further, beta-lactam antimicrobials, e.g. cefazolin, are 
ineffective against MRSP [39]. In our study, screening for 
MDR bacteria had been performed on the 26 dogs that 
were classified as risk patients. Six of these were found 
to be MRSP carriers. Risk patients (those with a history 
of recurrent ear or skin infection, prolonged or numer-
ous hospital visits or antimicrobial treatments, as well 
as patients with SSI or suppurative wound infection 
or contact with an animal carrying MDR bacteria) are 
screened in our hospital for MDR bacteria such as MRSP 
on admission. Previous data show that the MRSP car-
riage rate is higher (9%) in these patients than in low-risk 
patients i.e. the general Finnish dog population (3%) [37, 
40, 41]. There is no reason to expect that the MRSP car-
riage rate would be higher in the non-screened patients 
in our study than in the general population. However, 
this assumption is prone to error and should be further 
investigated in future prospective studies. Active surveil-
lance of MRSP has been carried out in our hospital since 
2010.
Surprisingly, lower body temperature was shown to be 
a protective factor for SSI in multivariable analysis. This 
is contradictory to previous reports, and without further 
evidence we are inclined to believe that this is an inciden-
tal finding. Perioperative hypothermia may lower resist-
ance to infection by inhibition of leukocyte migration, 
phagocytosis, and decreased cytokine synthesis, predis-
posing to SSI [42]. However, a retrospective study on 777 
dogs and cats found no significant difference in the analy-
sis of temperature data between animals with infected 
and uninfected wounds [43].
The main limitation of the study was the retrospective 
design, and the inclusion of data from several different 
procedures. However, the latter was considered neces-
sary to reach adequate statistical power for the risk fac-
tor analysis. Due to the retrospective design, missing data 
in some variables may introduce bias to our results. Data 
regarding the duration of anaesthesia and surgery were 
missing in 21.2% and 5.9% of the dogs, respectively; for 
10.6% of dogs, there was no follow-up information. The 
preoperative variables of the dogs with no follow-up 
information did not differ from the rest of the data, so we 
could assume that the SSI rate in this population does not 
differ significantly from that of the dogs with follow-up 
information.
This study identified several hospital practices that 
should be improved. The practice of performing bacterial 
culture in cases with suspected SSI should be reinforced, 
as it was performed in only 65.2% of the dogs with SSI. 
Anaesthesia and surgical records should be kept more 
meticulously, and the timing of antimicrobial adminis-
tration should be more accurate. Surgical safety check-
lists have been shown to reduce the risk of SSIs, [44] and 
the use of a checklist has now been implemented in our 
hospital.
Conclusions
With the Nordic antimicrobial policy of using only pro-
phylactic antimicrobial administration in canine ortho-
paedic and neurosurgeries, the overall SSI rate was 
satisfactory and comparable to previously published data. 
However, as there was variation in the SSI rate between 
different procedures, it should be further evaluated if cer-
tain procedures, such as arthrodesis, would benefit from 
postoperative antimicrobial administration. The compli-
ance with in-house and national protocols was excellent 
regarding both the adherence to using prophylaxis only 
in these procedures and the choice of prophylactic anti-
microbial, but there was room for improvement in the 
timing of prophylaxis. Carriage of MRSP was shown to 
be a significant risk factor for SSI. More detailed and pro-
spective studies are warranted to investigate the need for 
prophylaxis in veterinary clean orthopaedic surgeries.
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